期刊
STEROIDS
卷 73, 期 3, 页码 280-288出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.steroids.2007.10.011
关键词
17 beta-butoxy-1,3,5(10)-estratrien-3-ol; antioxidant neuroprotection; chemical shield; steroidal paro-quinol; hydroxyl radical; oxidative stress
资金
- NCRR NIH HHS [S10 RR012023-01, RR 12028] Funding Source: Medline
- NINDS NIH HHS [NS 44765, R01 NS044765-05, R01 NS044765-01, R01 NS044765, R01 NS044765-04, R01 NS044765-02, R01 NS044765-02S1, R01 NS044765-03] Funding Source: Medline
Antioxidant action is an important component of the complex neuroprotective effect of estrogens. Combining theoretical prediction and subsequent experimental confirmation by chemical and in vitro paradigms, this study focused on the mechanistic aspects of hydroxyl radical scavenging by 17 beta-butoxy-1,3,5(10)-estratrien-3-ol, a synthetic derivative of 17 beta-estradiol with increased potency to inhibit lipid peroxidation and reduced affinity to estrogen-receptors compared to the endogenous hormone. In the process that acts as a chemical shield, the phenolic A-ring turns into 10 beta-hydroxy-17 beta-butoxy-1,3,5(10)-estratrien-3-one, a non-aromatic paro-quinol, upon capturing hydroxyl radicals, which results in the complete loss of estrogen-receptor affinity and antioxidant activity. However, the parent compound is apparently recovered in brain tissue from this para-quinol via enzyme-catalyzed NAD(P)H-dependent reductive aromatization without causing oxidative stress. Taken together, our report argues for a previously unrecognized antioxidant cycle for estrogen-derived compounds. (C) 2007 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据